EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Adjunctive neodymium-doped yttrium aluminum garnet laser therapy for periodontitis in type 2 diabetes: A randomized controlled trial

Adjunktive Neodymium-dotierte Yttrium-Aluminium-Granat-Lasertherapie bei Parodontitis bei Typ-2-Diabetes: randomisierte kontrollierte Studie

Lijun He, Haifeng Hu, Yunhan Wang, Yue Yang iD

Journal of International Medical Research · 2026-11 · 54 (11)

DOI: 10.1177/03000605261489340 ↗

Auf einen Blick

Bei 120 Patient:innen mit Parodontitis und Typ-2-Diabetes war die zusätzliche Nd:YAG-Lasertherapie nach 6 Monaten mit geringerer Taschentiefe verbunden als die konventionelle nichtchirurgische Therapie allein.

Fragestellung

Verbessert eine zusätzliche neodymium-doped yttrium aluminum garnet-Lasertherapie zur konventionellen nichtchirurgischen Parodontaltherapie die baseline-adjustierte Taschentiefe nach 6 Monaten stärker als die alleinige Standardtherapie?

Methode

Randomisierte kontrollierte Studie mit 120 Patient:innen; 1:1-Zuteilung zu Laser plus konventioneller nichtchirurgischer Parodontaltherapie oder alleiniger konventioneller nichtchirurgischer Parodontaltherapie; Follow-up 6 Monate.

Ergebnisse

Baseline-adjustierte 6-Monats-Taschentiefe: adjusted difference −0,70 mm (95 %-KI −0,84 bis −0,56; p < 0,001). Auch klinischer Attachmentlevel, Blutung auf Sondieren, HbA1c und Nüchternplasmaglukose waren günstiger; Gingivarezession war höher.

Einschränkungen

Die glykemischen Variablen waren sekundäre Endpunkte; die Nachbeobachtung war auf 6 Monate begrenzt.

Schlussfolgerung der Autor:innen

Die zusätzliche neodymium-doped yttrium aluminum garnet-Lasertherapie war mit einer stärkeren kurzfristigen Verbesserung parodontaler klinischer Outcomes verbunden als die alleinige konventionelle nichtchirurgische Therapie.

Kernaussagen

  • Taschentiefe nach 6 Monaten um 0,70 mm geringer
  • Auch HbA1c und Nüchternplasmaglukose günstiger
  • Keine schweren behandlungsbedingten unerwünschten Ereignisse

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of International Medical Research, online erschienen am 02.11.2026. Verfasst von Lijun He und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Hospital of Chengdu University, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Lasers, Solid-State, Periodontitis. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Project of Affiliated Hospital of Chengdu University.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine whether adjunctive neodymium-doped yttrium aluminum garnet laser therapy added to conventional nonsurgical periodontal therapy provides greater improvement in baseline-adjusted 6-month probing depth than conventional nonsurgical periodontal therapy alone in patients with periodontitis and type 2 diabetes mellitus.

Methods

This randomized controlled trial included 120 patients with periodontitis and type 2 diabetes mellitus. Participants were randomly assigned in a 1:1 ratio to the laser group (conventional nonsurgical periodontal therapy plus adjunctive neodymium-doped yttrium aluminum garnet laser therapy, n = 60) or the control group (conventional nonsurgical periodontal therapy alone, n = 60). Conventional nonsurgical periodontal therapy comprised scaling and root planing with standardized home oral-hygiene instruction and reinforcement. Periodontal and glycemic outcomes were assessed at baseline and 6 months. The primary outcome was the between-group difference in the 6-month mean probing depth, adjusted for baseline probing depth using analysis of covariance. Secondary outcomes included baseline-adjusted between-group differences in clinical attachment level, bleeding on probing-positive sites, gingival recession, glycosylated hemoglobin, and fasting plasma glucose level.

Results

Baseline characteristics were generally comparable between groups, except a modest difference in mean gingival recession. Based on the primary analysis, the baseline-adjusted 6-month mean probing depth was significantly lower in the laser group than in the control group (adjusted difference, −0.70 mm (95% confidence interval, −0.84 to −0.56) p < 0.001). Baseline-adjusted differences also favored the laser group for clinical attachment level (−0.67 mm; 95% confidence interval, −0.79 to −0.55), bleeding on probing-positive sites (−11.3 percentage points; 95% confidence interval, −13.9 to −8.7), glycosylated hemoglobin (−0.26%; 95% confidence interval, −0.34 to −0.17), and fasting plasma glucose level (−0.62 mmol/L; 95% confidence interval, −0.81 to −0.44) (all p < 0.001). Gingival recession was slightly higher in the laser group after baseline adjustment (+0.09 mm; 95% confidence interval, 0.03 to 0.14; p = 0.004). No serious treatment-related adverse events were recorded.

Conclusions

Adjunctive neodymium-doped yttrium aluminum garnet laser therapy was associated with greater short-term improvement in periodontal clinical outcomes than conventional nonsurgical periodontal therapy alone. Favorable changes in secondary glycemic outcomes were also observed; however, these results should be interpreted cautiously because cautiously because glycemic variables were secondary endpoints, and the follow-up duration was limited to 6 months. Research registration number researchregistry12005.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Lasers, Solid-StatePeriodontitisHumansFemaleMaleMiddle AgedTreatment OutcomeGlycated HemoglobinBlood GlucoseAged

Stichwörter der Autor:innen

Nonsurgical periodontal therapybleeding on probingclinical attachment levelglycemic controlscaling and root planing

Substanzen

Glycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • The Affiliated Hospital of Chengdu University, China.

ORCID-Profile: Yue Yang

Förderung

  • Project of Affiliated Hospital of Chengdu University

Zitieren

APA

He, L., Hu, H., Wang, Y., & Yang, Y. (2026). Adjunctive neodymium-doped yttrium aluminum garnet laser therapy for periodontitis in type 2 diabetes: A randomized controlled trial. Journal of International Medical Research, 54(11). https://doi.org/10.1177/03000605261489340

Vancouver

He L, Hu H, Wang Y, Yang Y. Adjunctive neodymium-doped yttrium aluminum garnet laser therapy for periodontitis in type 2 diabetes: A randomized controlled trial. Journal of International Medical Research. 2026;54(11). doi:10.1177/03000605261489340

BibTeX
@article{He2026,
  author = {He, Lijun and Hu, Haifeng and Wang, Yunhan and Yang, Yue},
  title = {Adjunctive neodymium-doped yttrium aluminum garnet laser therapy for periodontitis in type 2 diabetes: A randomized controlled trial},
  journal = {Journal of International Medical Research},
  year = {2026},
  volume = {54},
  number = {11},
  doi = {10.1177/03000605261489340}
}
Kostenlos starten →